After 5 Years, Acid-Reducer Is Back on the Market

(MedPage Today) — The FDA has approved a reformulated version of ranitidine (Zantac), more than 5 years after requesting the antacid be pulled from shelves over concerns that it could break down into a carcinogen.
Federal regulators announced…